We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

By HospiMedica International staff writers
Posted on 26 May 2023
Print article
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts. In cardiac surgery, risk scores provided by The Society of Thoracic Surgeons (STS) are often used to evaluate a patient's procedural risk. While these scores remain vital for hospitals to assess and improve their performance, they are drawn from population-wide data, which can fall short of accurately predicting risk for specific patients with complex pathologies.

Now, cardiovascular surgeons and data science specialists at Mount Sinai (New York, NY, USA) have developed a machine learning-based model that predicts mortality risk for individual cardiac surgery patients, offering a considerable performance advantage over current population-based models. This data-driven algorithm, built on extensive electronic health records (EHR), is the first institution-specific model of its kind for pre-surgery cardiac patient risk assessment. It allows healthcare providers to determine the optimal treatment strategy for each patient.

The team theorized that models based on EHR data from their own institution, created via machine learning, could provide a useful solution. Using routinely gathered EHR data, they developed a robust machine learning framework to generate a risk prediction model for post-surgery mortality that is customized to both the patient and the hospital. This model incorporates vital data about Mount Sinai’s patient population, including demographic, socioeconomic, and health characteristics. This is in contrast to population-based models like STS, which rely on data from various health systems across the U.S. The effectiveness of this approach is further enhanced by an efficient open-source prediction algorithm called XGBoost, which assembles a group of decision trees by progressively focusing on harder-to-predict segments of training data.

The research team utilized XGBoost to model 6,392 cardiac surgeries conducted at The Mount Sinai Hospital from 2011 to 2016, encompassing heart valve procedures, coronary artery bypass grafts, aortic resections, replacements, or anastomoses, and reoperative cardiac surgeries, which significantly increase mortality risk. The team then compared the performance of their model to STS models for the same patient sets. The study found that the XGBoost model outshone STS risk scores for mortality in all frequently performed cardiac surgery categories for which STS scores were designed. The predictive performance of the XGBoost model across all types of surgeries was also high, indicating the potential of machine learning and EHR data for constructing effective institution-specific models.

“The standard-of-care risk models used today are limited by their applicability to specific types of surgeries, leaving out significant numbers of patients undergoing complex or combination procedures for which no models exist,” said senior author Ravi Iyengar, PhD, the Dorothy H. and Lewis Rosenstiel Professor of Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai, and Director of the Mount Sinai Institute for Systems Biomedicine. “Our team rigorously combined electronic health record data and machine learning methods to demonstrate for the first time how individual institutions can build their own risk models for post-cardiac surgery mortality.”

Related Links:
Mount Sinai 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
3 Channel ECG Machine
ECG-703

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.